Immunology/Inflammation
Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
- 5-Lipoxygenase(11)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(12)
- IκB/IKK(67)
- AP-1(6)
- KEAP1-Nrf2(65)
- NOD1(1)
- TLR(140)
- NF-κB(241)
- Interleukin Related(171)
- 15-lipoxygenase(2)
- Others(63)
- Aryl Hydrocarbon Receptor(36)
- CD73(14)
- Complement System(58)
- Galectin(12)
- IFNAR(25)
- NO Synthase(77)
- NOD-like Receptor (NLR)(51)
- STING(110)
- Reactive Oxygen Species(465)
- Apoptosis(802)
- FKBP(20)
- eNOS(5)
- iNOS(29)
- nNOS(20)
- Glutathione(57)
- Adaptive Immunity(222)
- Allergy(130)
- Arthritis(34)
- Autoimmunity(190)
- Gastric Disease(101)
- Immunosuppressants(39)
- Immunotherapeutics(5)
- Innate Immunity(593)
- Pulmonary Diseases(119)
- Reactive Nitrogen Species(55)
- Reactive Sulfur Species(28)
- Specialized Pro-Resolving Mediators(50)
- Cyclic GMP-AMP Synthase(2)
- BCL6(3)
- CD20(3)
- CD22
- CD28(1)
- FAP(7)
- PSMA(7)
- Nuclear Factor of activated T Cells (NFAT)(1)
- Glycoprotein VI(1)
- Tim3(2)
- Hapten(1)
- Nectin-4(2)
Immunology/Inflammation 相关产品(4245)
- GC91884DSPE-PEG(2000)-MannoseCAS: 1829524-73-3纯度: >95.00%
DSPE-PEG(2000)-Mannose已被用于制备脂质体和混合胶束,用于在体外和体内将抗癌剂递送至肿瘤相关巨噬细胞TAM。
- GC91909Fenoprofen-13C6 (sodium salt hydrate)CAS: 2687960-29-6纯度: >98.00%
Fenoprofen-13C6 (sodium salt hydrate)旨在用作通过GC或LC-MS定量非诺洛芬的内标。
- GC91921FenclofenacCAS: 34645-84-6纯度: >95.00%
Fenclofenac是一种非甾体抗炎药(NSAID)和COX抑制剂(COX-1和COX-2的IC50分别为7和4μM)。
- GC91962Actinobolin (hemisulfate)CAS: 18802-17-0纯度: >98.00%
Actinobolin (hemisulfate)是一种在假单胞菌中发现的微生物代谢物,具有抗生素和抗癌活性。
- GC91973Decanoyl-L-carnitine-d9 (chloride)CAS: 2847775-92-0纯度: >99.00%
Decanoyl-L-carnitine-d9 (chloride)旨在用作通过GC或LC-MS定量癸酰基-L-肉碱的内标。
- GC91977TrkB Agonist Prodrug R13CAS: 1609067-49-3纯度: >95.00%
TrkB Agonist Prodrug R13(R13)是原肌球蛋白相关激酶B(TrkB)激活剂7,8-二羟基黄酮的前药形式。
- GC91985Alloisolithocholic Acid-d4CAS: 2410277-60-8纯度: >99.00%
Alloisolithocholic Acid-d4用于GC-或LC-MS定量别异石胆酸的内标。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC91789 | LB244 | - | >95.00% | |
LB244 is an irreversible STING antagonist. | ||||
| GC91805 | DB2313 (hydrochloride) | - | >98.00% | |
DB2313 is an inhibitor of the transcription factor PU. | ||||
| GC91820 | PDIC-NS | - | >95.00% | |
PDIC-NS is an activator of stimulator of interferon genes (STING). | ||||
| GC91884 | DSPE-PEG(2000)-Mannose | 1829524-73-3 | >95.00% | |
DSPE-PEG(2000)-Mannose已被用于制备脂质体和混合胶束,用于在体外和体内将抗癌剂递送至肿瘤相关巨噬细胞TAM。 | ||||
| GC91887 | Methyl Salicylate-d4 | 1219802-12-6 | >99.00% | |
Methyl Salicylate-d4用于GC-或LC-MS定量水杨酸甲酯的内部标准。 | ||||
| GC91904 | CNBSF | 3829-23-0 | 不显示 | |
CNBSF是谷胱甘肽s -转移酶π 1-1 (GSTP1-1)和GST α 1-1 (GSTA1;ic50 = 21 μM和1.4 μM)。 | ||||
| GC91909 | Fenoprofen-13C6 (sodium salt hydrate) | 2687960-29-6 | >98.00% | |
Fenoprofen-13C6 (sodium salt hydrate)旨在用作通过GC或LC-MS定量非诺洛芬的内标。 | ||||
| GC91910 | Ferroptosis Inhibitor D1 | - | >98.00% | |
Ferroptosis Inhibitor D1是一种自由基清除剂和铁下垂抑制剂。 | ||||
| GC91911 | Napirimus | 70696-66-1 | >95.00% | |
Napirimus是一种免疫抑制剂。 | ||||
| GC91913 | NS 3861 | 216853-59-7 | >98.00% | |
NS 3861是一种神经元烟碱型乙酰胆碱受体(nAChR)激动剂。 | ||||
| GC91920 | Rhein-13C6 | - | >95.00% | |
Rhein-13C6旨在用作GC或LC-MS定量大黄酸的内标。 | ||||
| GC91921 | Fenclofenac | 34645-84-6 | >95.00% | |
Fenclofenac是一种非甾体抗炎药(NSAID)和COX抑制剂(COX-1和COX-2的IC50分别为7和4μM)。 | ||||
| GC91933 | E17241 | 1060968-92-4 | >95.00% | |
E17241是编码ATP结合盒转运蛋白1的基因ABCA1表达的诱导剂;亚家族A(ABCA1)。 | ||||
| GC91939 | Phytantriol | 74563-64-7 | >95.00% | |
Phytantriol是一种脂肪醇,已用于形成液晶纳米颗粒(LCNP)和立方体。 | ||||
| GC91947 | BH400 | - | >95.00% | |
BH400是过氧化物酶体增殖物激活受体α (PPARα)的激动剂和干扰素基因刺激因子抑制剂(STING;Ic50 = 8.1 μm)。 | ||||
| GC91949 | LIBX-A401 | - | >95.00% | |
LIBX-A401是长链酰基辅酶A合成酶4的抑制剂(ACSL4;IC50=0.38μM)。 | ||||
| GC91956 | SB-02024 | 2126737-28-6 | >98.00% | |
SB-02024是液泡蛋白分选34的抑制剂(VPS34;IC50=5nM)。 | ||||
| GC91962 | Actinobolin (hemisulfate) | 18802-17-0 | >98.00% | |
Actinobolin (hemisulfate)是一种在假单胞菌中发现的微生物代谢物,具有抗生素和抗癌活性。 | ||||
| GC91966 | Ppc-1 | 1245818-17-0 | 不显示 | |
Ppc-1是一种异戊二烯基喹啉羧酸,最初从假念珠菌中分离出来,具有多种生物活性。 | ||||
| GC91967 | LMTK3 Inhibitor C28 | 2764850-23-7 | >98.00% | |
LMTK3 Inhibitor C28是一种多激酶抑制剂。 | ||||
| GC91973 | Decanoyl-L-carnitine-d9 (chloride) | 2847775-92-0 | >99.00% | |
Decanoyl-L-carnitine-d9 (chloride)旨在用作通过GC或LC-MS定量癸酰基-L-肉碱的内标。 | ||||
| GC91977 | TrkB Agonist Prodrug R13 | 1609067-49-3 | >95.00% | |
TrkB Agonist Prodrug R13(R13)是原肌球蛋白相关激酶B(TrkB)激活剂7,8-二羟基黄酮的前药形式。 | ||||
| GC91985 | Alloisolithocholic Acid-d4 | 2410277-60-8 | >99.00% | |
Alloisolithocholic Acid-d4用于GC-或LC-MS定量别异石胆酸的内标。 | ||||
| GC91986 | Allolithocholic Acid-d4 | - | >99.00% | |
Allolithocholic Acid-d4旨在用作GC或LC-MS定量异石胆酸的内标。 | ||||
